🇨🇦 13-valent pneumococcal conjugate vaccine in Canada

13-valent pneumococcal conjugate vaccine (13-valent-pneumococcal-conjugate-vaccine) regulatory status in Canada.

Marketing authorisation

13-valent pneumococcal conjugate vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is 13-valent pneumococcal conjugate vaccine approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for 13-valent pneumococcal conjugate vaccine in Canada?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.